Aktive Positionen von Marc Dechamps
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| OSE IMMUNOTHERAPEUTICS | Direktor/Vorstandsmitglied | 19.06.2024 | - |
| Independent Dir/Board Member | 19.06.2024 | - |
Karriereverlauf von Marc Dechamps
Ehemalige bekannte Positionen von Marc Dechamps
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Delphi Genetics SA
 Delphi Genetics SA BiotechnologyHealth Technology Delphi Genetics SA develops products and technologies for gene cloning and protein expression in bacteria. It offers deoxyribonucleic acid (DNA), antibody development, molecular biology, protein purification, vector adaption, and DNA immunization services. The company was founded by Philippe Gabant, Michel Milinkovitch, and Cedric Szpirer in 2001 and is headquartered in Charleroi, Belgium. | Vorstandsvorsitzender | - | 01.07.2017 |
eTheRNA immunotherapies NV
 eTheRNA immunotherapies NV BiotechnologyHealth Technology eTheRNA immunotherapies NV develops novel immunotherapies to overcome cancers and infectious diseases. The company was founded by Carlo Heirman, Kris Thielemans and Sonja van Meirvenne in January 21, 2013 and is headquartered in Niel, Belgium. | Direktor/Vorstandsmitglied | - | - |
| Corporate Officer/Principal | - | - |
Statistik
International
| Belgien | 3 |
| Frankreich | 2 |
Operativ
| Director/Board Member | 2 |
| Chief Executive Officer | 1 |
| Corporate Officer/Principal | 1 |
Sektoral
| Health Technology | 4 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| OSE IMMUNOTHERAPEUTICS | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Delphi Genetics SA
Delphi Genetics SA BiotechnologyHealth Technology Delphi Genetics SA develops products and technologies for gene cloning and protein expression in bacteria. It offers deoxyribonucleic acid (DNA), antibody development, molecular biology, protein purification, vector adaption, and DNA immunization services. The company was founded by Philippe Gabant, Michel Milinkovitch, and Cedric Szpirer in 2001 and is headquartered in Charleroi, Belgium. | Health Technology |
eTheRNA immunotherapies NV
eTheRNA immunotherapies NV BiotechnologyHealth Technology eTheRNA immunotherapies NV develops novel immunotherapies to overcome cancers and infectious diseases. The company was founded by Carlo Heirman, Kris Thielemans and Sonja van Meirvenne in January 21, 2013 and is headquartered in Niel, Belgium. | Health Technology |
- Börse
- Insiders
- Marc Dechamps
- Erfahrung
